CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Executive or director change
- 4 Other acquisition Chief Financial Officer acquired 50,000 shares (other)
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- NT 10-Q Other NT 10-Q
- SC 14F1 Other SC 14F1
- 10-K/A Report 10-K/A
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Executive or director change
- NT 10-K Other NT 10-K
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Executive VP & CMO acquired 43,333 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 56,250 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 66,083 shares (grant or award)
Page 40 of 63 · 1,250 filings